Structure-pharmacokinetic relationships for misonidazole analogues in mice
- PMID: 7273265
- DOI: 10.1007/BF00253009
Structure-pharmacokinetic relationships for misonidazole analogues in mice
Abstract
We have compared the mouse pharmacokinetics of six analogues of the hypoxic cell sensitizer misonidazole (MISO). The analogues were all uncharged and similar in redox potential, but widely different in octanol-water partition coefficient (range 0.026-1.5). Lipophilic analogues were cleared mainly by metabolism and non-linear elimination kinetics were seen at high doses. Hydrophilic analogues, including desmethylmisonidazole, SR-2508, and SR-2555, were removed principally by renal clearance exhibiting linear elimination kinetics. Lipophilic analogues were cleared more rapidly after hepatic microsomal enzyme induction by phenobarbitone, whereas the kinetics of hydrophilic analogues were unaffected. Low-dose clearance was similar for most of the analogues. But the hydrophilic SR-2555 was cleared twice as quickly as MISO, and the lipophilic Ro 07-0913 seven times faster than MISO. Plasma protein binding was low for all the analogues. The significance of these results for the predictive value of the mouse as a model for man is discussed.
Similar articles
-
Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.Biochem Pharmacol. 1982 Oct 1;31(19):3041-6. doi: 10.1016/0006-2952(82)90077-6. Biochem Pharmacol. 1982. PMID: 6897355
-
Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.Cancer Chemother Pharmacol. 1980;5(1):27-37. doi: 10.1007/BF00578559. Cancer Chemother Pharmacol. 1980. PMID: 7460192
-
The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):473-6. doi: 10.1016/0360-3016(82)90664-2. Int J Radiat Oncol Biol Phys. 1982. PMID: 7107369
-
Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.J Pharmacol Exp Ther. 1981 Dec;219(3):669-74. J Pharmacol Exp Ther. 1981. PMID: 7299690
-
Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.Br J Cancer. 1980 Feb;41(2):268-76. doi: 10.1038/bjc.1980.39. Br J Cancer. 1980. PMID: 7370166 Free PMC article.
Cited by
-
Nitroimidazoles and imaging hypoxia.Eur J Nucl Med. 1995 Mar;22(3):265-80. doi: 10.1007/BF01081524. Eur J Nucl Med. 1995. PMID: 7789400 Review.
-
Functionalized Nitroimidazole Scaffold Construction and Their Pharmaceutical Applications: A 1950-2021 Comprehensive Overview.Pharmaceuticals (Basel). 2022 Apr 30;15(5):561. doi: 10.3390/ph15050561. Pharmaceuticals (Basel). 2022. PMID: 35631389 Free PMC article. Review.
-
Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia.Cancer Sci. 2009 Aug;100(8):1366-73. doi: 10.1111/j.1349-7006.2009.01195.x. Epub 2009 May 14. Cancer Sci. 2009. PMID: 19459851 Free PMC article. Review.
-
Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in mice.Br J Cancer. 1989 May;59(5):667-73. doi: 10.1038/bjc.1989.138. Br J Cancer. 1989. PMID: 2736198 Free PMC article.
-
Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.Br J Cancer. 1982 Aug;46(2):249-59. doi: 10.1038/bjc.1982.190. Br J Cancer. 1982. PMID: 7150475 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials